Use access key #2 to skip to page content.
$39.75 -0.68 (-1.68%)
7/3/2008 1:00 PM

ImClone Systems, Inc. (IMCL)

CAPS Rating:
****

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

View All Commentary (IMCL)

Recs

0

Avatar tiobueno (29.02) Submitted: 9/21/07 1:35 PM : Outperform Start Price: $42.70 IMCL Score: 10.38

Insider (secform4.com)

Report this Post Replies: 0 | Reply

Featured Broker Partners